-
Optum Rx Ends Reauthorization for Many Chronic Disease Drugs
19 Mar 2025 18:04 GMT
… term condition
Requires chronic treatment
Long-term drug effectiveness is established
… Ofev
Pulmonary arterial hypertension drugs: Revatio, Liqrev, Uptravi, Tracleer, Letairis, Adcirca, … for procedures and services in Medicare Advantage plans.
The healthcare …
-
Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States
10 Feb 2025 10:54 GMT
… and Drug Administration (U.S.FDA) for Natco’s Abbreviated New Drug Application … equivalent of Tracleer Tablets for Oral Suspension of Actelion Pharmaceuticals US, Inc … Suspension are indicated for the treatment of pulmonary arterial hypertension (PAH …
-
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension
10 Feb 2025 10:17 GMT
… Food and Drug Administration (FDA) for Natco … Tracleer tablets for oral suspension of Actelion Pharmaceuticals … for the treatment of pulmonary arterial … pharmaceutical products, including branded and generic formulations, complex generics, biotechnology …
-
GoodRx : 10 Bosentan (Tracleer) Side Effects and How to Manage Them
25 Jul 2024 22:38 GMT
… savings to related medications
info_outlinedPromotional disclosure … , causes, and treatments of PAH.
Portable … infection
During clinical trials, respiratory tract infections … Food and Drug Administration.
Actelion Pharmaceuticals US. (2024). Tracleer (bosentan …
-
Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 43, Status: Authorised
02 May 2024 13:20 GMT
Treatment of PAH
In PAH, Tracleer film-coated tablets added … than placebo (a dummy treatment) in improving the distance … support the use of the medicine in this group.
In … weeks of treatment.
Treatment of systemic sclerosis with digital ulcers
Tracleer was …
-
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies
30 Apr 2024 02:50 GMT
… the EDN pathway include bosentan (Tracleer; Actelion Pharmaceuticals US, Inc), ambrisentan ( … and macitentan (Opsumit; Actelion Pharmaceuticals Ltd). Drugs that target the PCN pathway … going to drive your initial treatment decision.”
According to Smith, …
-
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
20 Jul 2023 06:30 GMT
… (clazosentan), for the treatment of cerebral vasospasm, a … delivering life-changing medicines to patients.
Financial … Tracleer® and Opsumit® are registered trademarks of Actelion Pharmaceuticals … Switzerland – a European biotech-hub – Idorsia is specialized …
-
Sosei Heptares acquires Idorsia's pharmaceuticals business in Japan and APAC (ex─China)
21 Jul 2023 08:54 GMT
… champions.
“The Japan pharmaceutical market, given its size … including Tracleer (bosentan), the world’s first oral medication for … (clazosentan), for the treatment of cerebral vasospasm, a … Switzerland – a European biotech-hub – Idorsia is specialized …
-
Relentless Decline in Small- and Mid-caps: Market Last week
14 Feb 2025 16:51 GMT
… ;s ‘very high’ tariffs, stating his intention to implement matching … approval for its abbreviated new drug application (ANDA) for … a generic version of Tracleer by Actelion Pharmaceuticals US Inc. The …
Rainbow Children's Medicare reported 10.18% rise in …
-
Markets Wilt Again On Trump Tariffs - Monday Market Report
10 Feb 2025 17:39 GMT
… approval for its abbreviated new drug application (ANDA) for … a generic version of Tracleer by Actelion Pharmaceuticals US Inc. The … partner for the ANDA, Lupin Pharmaceuticals, Inc. (Lupin) will … .
Rainbow Children's Medicare (-1.02%) reported 10.18% …
About
© 1995-2025